PrøvGOLD- Free

"We no longer need to endure the ravages of ageing"
BioSpectrum Asia|BioSpectrum Asia Feb 2024
Ageing is a natural part and the "last mile" of a human development programme, and Gero pioneered ways to understand, measure, and, ultimately, control its progression. Gero, a longevity biotech physics-enabled biotechnology company from Singapore is creating therapeutics against chronic diseases with a mission to slow down human ageing itself.
"We no longer need to endure the ravages of ageing"

Gero's machine-learning platform possesses the unique capability to identify potential therapeutic targets for fibrotic diseases by analysing extensive human-based datasets. These discoveries could potentially reshape the landscape of anti-ageing research. In January 2023, the American pharmaceutical giant entered the longevity field by collaborating with Gero. Maxim Kholin, Founder of Gero, takes us through the exciting science of antiageing/longevity and why it is no longer confined to the realm of science fiction. Edited excerpts:

What technologies is Gero using to solve ageing?

To my knowledge, we are the only company that is using physics to model biology this way. For example, consider how we approach this. People can predict the trajectory of planetary movement, much like how we analyse vast medical datasets, such as electronic medical records. We discern patterns in the data, akin to predicting future states using equations of motion, and anticipate how a patient's condition may change after therapy, similar to how Gmail suggests sentence completions as you type. Our internal projects are focused on addressing the challenge of ageing, including partial rejuvenation and halting the ageing process. Furthermore, we're actively seeking new rounds of investment to advance anti-ageing therapies and undertake additional projects related to age-related diseases.

Denne historien er fra BioSpectrum Asia Feb 2024-utgaven av BioSpectrum Asia.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra BioSpectrum Asia Feb 2024-utgaven av BioSpectrum Asia.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA BIOSPECTRUM ASIASe alt
"We are dedicated to helping people of all ages see brilliantly"
BioSpectrum Asia

"We are dedicated to helping people of all ages see brilliantly"

The global leader in eye care for over 75 years, Alcon Inc. strives to help eye care professionals strengthen their practices and serve patients better, improving visual health worldwide. Through its innovative eye care portfolios, Alcon has established operations in 56 countries and serves patients in 140 countries. Jason Hoffe, Vice President, APAC Vision Care, Alcon, responsible for driving the vision care business in the region shares opportunities exist for the company and new developments in eye healthcare that are cause for optimism for patients in the region.

time-read
5 mins  |
BioSpectrum Asia Jan 2025
Singapore Turns Tech Beacon with Revolutionary Pharma Manufacturing & Digital Transformation
BioSpectrum Asia

Singapore Turns Tech Beacon with Revolutionary Pharma Manufacturing & Digital Transformation

In the current pharmaceutical manufacturing environment, linking information technology (IT) with operational technology (OT) systems is increasingly vital. This integration enables a seamless exchange of information between these two historically separate domains - one focused on data management and the other on overseeing physical operations. This enables various aspects of the manufacturing process to gain insights from one another to boost efficiency and refine strategic decision-making. Digital transformation is essential for directing companies through the complexities of implementation and ensuring a seamless shift to a data-driven, digitally optimized manufacturing landscape.

time-read
6 mins  |
BioSpectrum Asia Jan 2025
Building the Future of Medicine
BioSpectrum Asia

Building the Future of Medicine

PRODUCT OF THE YEAR 2024 - Needle Free Injection System technology by IntegriMedical

time-read
4 mins  |
BioSpectrum Asia Jan 2025
Emerging Leader in Cell & Gene Therapy
BioSpectrum Asia

Emerging Leader in Cell & Gene Therapy

STARTUP OF THE YEAR 2024 - ImmunoACT

time-read
3 mins  |
BioSpectrum Asia Jan 2025
Improving Access for Respiratory Healthcare
BioSpectrum Asia

Improving Access for Respiratory Healthcare

STARTUP OF THE YEAR 2024 - Aevice Health

time-read
4 mins  |
BioSpectrum Asia Jan 2025
Making an Impact with a 'CliKX'
BioSpectrum Asia

Making an Impact with a 'CliKX'

Dr Lynne Lim, Co-Founder & Chief Executive Officer, NousQ

time-read
4 mins  |
BioSpectrum Asia Jan 2025
Eyeing 20-20 Vision of Excellence
BioSpectrum Asia

Eyeing 20-20 Vision of Excellence

Dr Jogin Desai, Co-Founder & Chief Executive Officer, Eyestem Research

time-read
4 mins  |
BioSpectrum Asia Jan 2025
Refining the Use of Radiation
BioSpectrum Asia

Refining the Use of Radiation

Dr Christian Behrenbruch, Managing Director and Group Chief Executive Officer (CEO), Telix Pharmaceuticals

time-read
3 mins  |
BioSpectrum Asia Jan 2025
Honouring Innovators in Asia's Thriving Life Sciences Sector
BioSpectrum Asia

Honouring Innovators in Asia's Thriving Life Sciences Sector

Asia has, indeed, become the new hub for growth and innovation, with no signs of losing steam. To recognise the Asian companies and individuals for their commendable performance and achievements during 2023 and 2024, BioSpectrum Asia Excellence Awards 2024 ceremony was held at Hotel Fort Canning in Singapore on December 6, 2024.

time-read
2 mins  |
BioSpectrum Asia Jan 2025
How To Control Indian Diabetes Growth
BioSpectrum Asia

How To Control Indian Diabetes Growth

World Diabetes Day, observed on November 14, reminds us of the growing impact of diabetes on global health and the urgent need for collective action to prevent, diagnose, and manage this chronic condition. In 2024, the theme 'Breaking Barriers, Bridging Gaps' underscores the critical importance of accessible, high-quality diabetes care, especially for underrepresented communities. The Government of India has taken many measures intending to reduce the prevalence of diabetes and alleviate its long-term complications, contributing to a healthier future for all citizens.

time-read
4 mins  |
December 2024

Vi bruker informasjonskapsler for å tilby og forbedre tjenestene våre. Ved å bruke nettstedet vårt samtykker du til informasjonskapsler. Finn ut mer